Reduced protein levels of both NGAL and MMP-9 have been detected in urine samples from bladder cancer patients with clinical relapse suggesting that reduced levels of these proteins may be used as indicators of tumor progression [26]. Here, LCN2 is linked to urinary bladder carcinoma.